| drug name | Liletta |
| classification | Intrauterine device (IUD) releasing levonorgestrel |
| pharmacokinetics | Levonorgestrel is released slowly from the IUD into the uterus, providing continuous, low-dose hormonal contraception. The exact pharmacokinetic details are not readily available in a generalized sense for a patient. It primarily acts by thickening cervical mucus and thinning the endometrium, preventing fertilization. The body's processing and removal of the drug are dependent on factors such as individual metabolism and interactions with other drugs, making a generalized pharmacokinetic profile difficult to provide. |
| suggested dosage | Liletta is a one-time placement device, not a daily medication. Dosage is not applicable. |
| indications | Contraception in appropriately selected individuals. Generally used for long-term, reversible contraception for women of reproductive age. |
| safety in pregnancy | Absolutely contraindicated if pregnancy is suspected or confirmed. If pregnancy is suspected or confirmed, the IUD must be removed. |
| safety in breastfeeding | Generally considered safe for use during breastfeeding. Hormonal levels in breast milk are very low and not expected to be harmful to the infant. |
| side effects | | 1 | Irregular bleeding (spotting, breakthrough bleeding, or prolonged bleeding), | | 2 | Abdominal pain | | 3 | Cramping | | 4 | Infection (rare but possible) | | 5 | Expulsion of the device | | 6 | Pain during insertion or removal | | 7 | Headache | | 8 | Mood changes | | 9 | Breast tenderness | | 10 | Nausea | | 11 | Fatigue |
|
| alternatives | |
| contraindications | | 1 | Suspected or confirmed pregnancy | | 2 | Known or suspected uterine abnormalities | | 3 | Pelvic inflammatory disease (PID) or other active pelvic infections | | 4 | Unexplained vaginal bleeding | | 5 | History of ectopic pregnancy | | 6 | Severe liver disease | | 7 | Known hypersensitivity to levonorgestrel or any components of the device | | 8 | History of uterine fibroids or tumors causing significant distortion | | 9 | Known or suspected uterine or cervical cancer | | 10 | Severe systemic illness or disease |
|
| interactions | No significant drug interactions are known with commonly prescribed medications. However, the information provided is not exhaustive and potential interactions should always be discussed with a healthcare provider. |
| warnings and precautions | | 1 | Regular check-ups with the healthcare provider are essential. | | 2 | It is crucial to disclose all medical conditions and medications to the healthcare provider before receiving any contraceptive treatment. | | 3 | Potential for expulsion or migration of the device must be taken into account. | | 4 | Atypical or persistent bleeding must be reported to the provider. |
|
| additional information | Liletta's efficacy is exceptionally high. The individual patient's response may differ, and the overall success rate and risks should always be discussed with a healthcare professional. This information is not a substitute for professional medical advice. Always consult a doctor or other qualified healthcare provider for any questions or concerns about your health or treatment. |
| patient age | 25 |
| patient weight | 70kg |
| note | This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment. |
